Showing results (31-40 of 76) with videos related to
Sort By:
Pageof 8
Journal of Clinical Lipidology|September 29, 2016
Efficacy and safety of gemcabene as add-on to stable statin therapy in hypercholesterolemic patientsEvan Stein, Harold Bays, Michael Koren, et al.Current Medical Research and Opinion|November 2, 2006
Lipid-lowering effects of colesevelam HCl in combination with ezetimibeHarold Bays, James Rhyne, Stacey Abby, et al.Current Medical Research and Opinion|September 11, 2008
Long-term (48-week) safety of ezetimibe 10 mg/day coadministered with simvastatin compared to simvastatin alone in patients with primary hypercholesterolemiaHarold Bays, Aditi Sapre, William Taggart, et al.Current Treatment Options in Cardiovascular Medicine|September 1, 2007
Adiposopathy: treating pathogenic adipose tissue to reduce cardiovascular disease riskHarold Bays, Helena W Rodbard, Alan Bruce Schorr, et al.Metabolic Syndrome and Related Disorders|March 10, 2012
Extended-release niacin/laropiprant effects on lipoprotein subfractions in patients with type 2 diabetes mellitusHarold Bays, Hilde Giezek, James M McKenney, et al.Circulation|April 27, 2011
Lapaquistat acetate: development of a squalene synthase inhibitor for the treatment of hypercholesterolemiaEvan A Stein, Harold Bays, Dennis O'Brien, et al.International Journal of Hypertension|May 9, 2013
Efficacy of Single-Pill Combination of Telmisartan 80 mg and Hydrochlorothiazide 25 mg in Patients with Cardiovascular Disease Risk Factors: A Prospective Subgroup Analysis of a Randomized, Double-Blind, and Controlled TrialHarold Bays, Pingjin Gao, Birgit Völker, et al.Journal of Clinical Lipidology|February 5, 2011
Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A(2) mass in statin-treated subjects with hypertriglyceridemiaMichael H Davidson, Kevin C Maki, Harold Bays, et al.Clinical Therapeutics|August 25, 2005
Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled studyMichael H Davidson, Harold Bays, James Rhyne, et al.Integrated Blood Pressure Control|May 3, 2013
Efficacy and tolerability of a single-pill combination of telmisartan 80 mg and hydrochlorothiazide 25 mg according to age, gender, race, hypertension severity, and previous antihypertensive use: planned analyses of a randomized trialDingliang Zhu, Harold Bays, Pingjin Gao, et al.Pageof 8